Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 4

Sponsor Class

NIH 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 181Gastrointestinal 26CNS 21Tumor-Agnostic 14Head & Neck 13Genitourinary 13Gynecologic 10Thoracic 7Other solid neoplasm 7Sarcoma 4Other hematologic neoplasm 1Lymphoid 1Endocrine 1Dermatologic 1

Conditions

Gliosarcoma 3Glioblastoma 3Brain Neoplasms 3Glioma 2Sarcoma 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 220Doxorubicin 210Cyclophosphamide 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 80Irinotecan 79pembrolizumab 75Radiation 69Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 57Surgical Procedures, Operative 56Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Lapatinib × Sarcoma × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT02101905 2024-11-06

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

National Cancer Institute (NCI)

Phase 1 Completed
29 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT00107003 2018-07-05

GW572016 to Treat Recurrent Malignant Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
9 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Gliosarcoma

NCT00099060 2014-01-27

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 1/2 Completed
24 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡